Hologic’s reports $268.4M profits in third quarter
Photo | Grant Welker
Hologic's Marlborough headquarters
Hologic, a Marlborough based medical technology company specializing in women's health, reported a net income of $268.4 million for the company’s third quarter in an earnings report released on Wednesday.
The new figure shows extensive growth when compared to the prior year’s third quarter in which Hologic earned $137.9 million in profits.
Cash flow from operations was $662.9 million in the third quarter. Through the closing of the $808-million acquisition of Finnish-French company Mobidiag Oy, Hologic repurchased approximately 3 million shares of its common stock for $188 million in the quarter, according to the press release.
Since the earnings report came out, Hologic's stock price has risen 2.6% on the NASDAQ to $73.62 per share, as of Thursday afternoon. That outpaces the whole of the Nasdaq, which has risen a collective 0.2% over the same time period.
"Hologic posted very strong financial results in our third fiscal quarter, with both revenue and EPS growth exceeding our guidance," said Steve MacMillan, the company’s chairman, president and CEO, in a press release.
WBJ Web Partners
Most Recent
Most Recent
0 Comments